Waer M |
New immunosuppressive agents for organ transplantation. |
1997 |
Acta Clin Belg |
pmid:9351290
|
Liang J et al. |
Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution. |
1999 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:10089303
|
Bracher A et al. |
Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90. |
2011 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:21636895
|
Li P et al. |
Structure of the N-terminal domain of human FKBP52. |
2003 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:12499534
|
Schreier MH |
Immunophilins and immunosuppression by cyclosporins and macrolide structures. |
1994 |
Acta Derm Venereol Suppl (Stockh) |
pmid:7521103
|
Segura S et al. |
Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. |
2005 |
Acta Derm. Venereol. |
pmid:16396803
|
Jungersted JM et al. |
Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. |
2011 |
Acta Derm. Venereol. |
pmid:21365172
|
Zattra E et al. |
Labial melanotic macule after application of topical tacrolimus: two case reports. |
2010 |
Acta Derm. Venereol. |
pmid:20814635
|
Hao D et al. |
Lymphocytic infiltration of the eyelid: two cases responding to tacrolimus and topical glucocorticoid. |
2013 |
Acta Derm. Venereol. |
pmid:23423497
|
Seo SR et al. |
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. |
2017 |
Acta Derm. Venereol. |
pmid:28512670
|
Mandelin J et al. |
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. |
2010 |
Acta Derm. Venereol. |
pmid:20169301
|
Ujiie H et al. |
Successful treatment of nail lichen planus with topical tacrolimus. |
2010 |
Acta Derm. Venereol. |
pmid:20169322
|
Honda Y et al. |
Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions. |
2015 |
Acta Derm. Venereol. |
pmid:25881714
|
Inoue T et al. |
Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. |
2006 |
Acta Derm. Venereol. |
pmid:16585982
|
Ortonne JP et al. |
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. |
2006 |
Acta Derm. Venereol. |
pmid:16585986
|
Tzung TY et al. |
Pimecrolimus and narrowband UVB as monotherapy or combination therapy in children and adolescents with atopic dermatitis. |
2006 |
Acta Derm. Venereol. |
pmid:16585987
|
Pitarch G et al. |
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. |
2006 |
Acta Derm. Venereol. |
pmid:16585995
|
Cunha PR |
Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. |
2006 |
Acta Derm. Venereol. |
pmid:16585998
|
Cunha PR and Rossi AB |
Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. |
2006 |
Acta Derm. Venereol. |
pmid:16585999
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|